{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:20:26Z","timestamp":1778048426027,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NCI","award":["U54 MD019970"],"award-info":[{"award-number":["U54 MD019970"]}]},{"name":"UTRGV seed grant","award":["UTRGV"],"award-info":[{"award-number":["UTRGV"]}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP210180"],"award-info":[{"award-number":["RP210180"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP230419"],"award-info":[{"award-number":["RP230419"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04744-4","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:54:40Z","timestamp":1774590880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Vivek K.","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhuvnesh P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu N.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali M.","family":"Yallapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everardo","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash C.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"1","key":"4744_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"Cancer J Clin"},{"issue":"1Suppl 1","key":"4744_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(1Suppl 1):4\u201313.","journal-title":"Hepatology"},{"issue":"5","key":"4744_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14737140.2025.2489651","volume":"25","author":"QB Wang","year":"2025","unstructured":"Wang QB, Li J, Zhang ZJ, Li YK, Liang YB, Chen XM, Luo WL, Lakang Y, Yang ZS, Liu GY, et al. The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cave and\/or right atrium: a systematic review and single-arm meta-analysis. Expert Rev Anticancer Ther. 2025;25(5):561\u201370.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"4744_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ajg.2013.160","volume":"108","author":"TM Welzel","year":"2013","unstructured":"Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108(8):1314\u201321.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4744_CR5","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1038\/s41598-021-88254-z","volume":"11","author":"H Kanno","year":"2021","unstructured":"Kanno H, Goto Y, Sasaki S, Fukutomi S, Hisaka T, Fujita F, Akagi Y, Okuda K. Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis. Sci Rep. 2021;11(1):9038.","journal-title":"Sci Rep"},{"issue":"5","key":"4744_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat reviews Gastroenterol Hepatol. 2021;18(5):293\u2013313.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"key":"4744_CR7","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Liang YB, Wang QB, Li YK, Chen XM, Luo WL, Lakang Y, Yang ZS, Wang Y, Li ZW, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2024;15:1519999.","journal-title":"Front Immunol"},{"key":"4744_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, Lakang Y, Liang YB, Chen XM, Zuo JX, et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2055\u201367.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"4744_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/hep.30211","volume":"69","author":"RA Hlady","year":"2019","unstructured":"Hlady RA, Sathyanarayan A, Thompson JJ, Zhou D, Wu Q, Pham K, Lee JH, Liu C, Robertson KD. Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma. Hepatology (Baltimore MD). 2019;69(2):639\u201352.","journal-title":"Hepatology (Baltimore MD)"},{"key":"4744_CR10","doi-asserted-by":"crossref","unstructured":"Toubert C, Guiu B, Al Taweel B, Assenat E, Panaro F, Souche FR, Ursic-Bedoya J, Navarro F, Herrero A. Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up! Cancers (Basel) 2022, 15(1).","DOI":"10.3390\/cancers15010232"},{"issue":"16","key":"4744_CR11","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-16-3171","volume":"23","author":"AG Duffy","year":"2017","unstructured":"Duffy AG, Ma C, Ulahannan SV, Rahma OE, Makarova-Rusher O, Cao L, Yu Y, Kleiner DE, Trepel J, Lee MJ, et al. Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. Clin Cancer Res. 2017;23(16):4633\u201341.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4744_CR12","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.18632\/aging.203425","volume":"13","author":"JH Xu","year":"2021","unstructured":"Xu JH, Guan YJ, Zhang YC, Qiu ZD, Zhou Y, Chen C, Yu J, Wang WX. ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. Aging. 2021;13(16):20395\u2013417.","journal-title":"Aging"},{"issue":"1","key":"4744_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12885-023-10987-z","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liang X, Lian Q, Liu L, Zhang B, Dong Z, Liu K. Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma. BMC Cancer. 2023;23(1):677.","journal-title":"BMC Cancer"},{"issue":"9","key":"4744_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674\u201387.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4744_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"4744_CR16","doi-asserted-by":"crossref","unstructured":"Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers 2021, 13(9).","DOI":"10.3390\/cancers13092053"},{"issue":"8","key":"4744_CR17","first-page":"928","volume":"22","author":"J Xiang","year":"2025","unstructured":"Xiang J, Li Y, Mei S, Ou Z, Wang L, Ke Y, Li Z. Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma. Cancer Biol Med. 2025;22(8):928\u201339.","journal-title":"Cancer Biol Med"},{"key":"4744_CR18","doi-asserted-by":"crossref","unstructured":"Marini M, Titiz M, Souza Monteiro de Ara\u00fajo D, Geppetti P, Nassini R, De Logu F. TRP channels in cancer: signaling mechanisms and translational approaches. Biomolecules 2023, 13(10).","DOI":"10.3390\/biom13101557"},{"issue":"1638","key":"4744_CR19","doi-asserted-by":"publisher","first-page":"20130108","DOI":"10.1098\/rstb.2013.0108","volume":"369","author":"F Lang","year":"2014","unstructured":"Lang F, Stournaras C. Ion channels in cancer: future perspectives and clinical potential. Philos Trans R Soc Lond B Biol Sci. 2014;369(1638):20130108.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4744_CR20","doi-asserted-by":"crossref","unstructured":"Chinreddy SR, Mashozhera NT, Rashrash B, Flores-Iga G, Nimmakayala P, Hankins GR, Harris RT, Reddy UK. Unraveling TRPV1\u2019s Role in Cancer: expression, modulation, and therapeutic opportunities with capsaicin. Molecules (Basel, Switzerland) 2024, 29(19).","DOI":"10.3390\/molecules29194729"},{"issue":"8","key":"4744_CR21","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.7150\/ijbs.59918","volume":"17","author":"L Li","year":"2021","unstructured":"Li L, Chen C, Chiang C, Xiao T, Chen Y, Zhao Y, Zheng D. The impact of TRPV1 on cancer pathogenesis and therapy: a systematic review. Int J Biol Sci. 2021;17(8):2034\u201349.","journal-title":"Int J Biol Sci"},{"issue":"7478","key":"4744_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12823","volume":"504","author":"E Cao","year":"2013","unstructured":"Cao E, Liao M, Cheng Y, Julius D. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature. 2013;504(7478):113\u20138.","journal-title":"Nature"},{"issue":"4","key":"4744_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jointm.2024.01.008","volume":"4","author":"J Chen","year":"2024","unstructured":"Chen J, Sun W, Zhu Y, Zhao F, Deng S, Tian M, Wang Y, Gong Y. TRPV1: The key bridge in neuroimmune interactions. J Intensive Med. 2024;4(4):442\u201352.","journal-title":"J Intensive Med"},{"key":"4744_CR24","doi-asserted-by":"crossref","unstructured":"Nie R, Liu Q, Wang X. TRPV1 is a potential tumor suppressor for its negative association with tumor proliferation and positive association with antitumor immune responses in pan-cancer. J Oncol 2022, 2022:6964550.","DOI":"10.1155\/2022\/6964550"},{"issue":"1","key":"4744_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41420-025-02674-8","volume":"11","author":"YN Hwang","year":"2025","unstructured":"Hwang YN, Park JH, Na HH, Kwon TH, Park JS, Chae S, Oh YT, Kim KC. Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy. Cell Death Discov. 2025;11(1):377.","journal-title":"Cell Death Discov"},{"issue":"26","key":"4744_CR26","doi-asserted-by":"publisher","first-page":"e2306916","DOI":"10.1002\/smll.202306916","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhou X, Yao L, Hu Q, Liu H, Zhao G, Wang K, Zeng J, Sun M, Lv C. Capsaicin Enhanced the efficacy of photodynamic therapy against osteosarcoma via a pro-death strategy by inducing ferroptosis and alleviating hypoxia. Small. 2024;20(26):e2306916.","journal-title":"Small"},{"key":"4744_CR27","doi-asserted-by":"publisher","first-page":"109270","DOI":"10.1016\/j.biopha.2019.109270","volume":"118","author":"C Xie","year":"2019","unstructured":"Xie C, Liu G, Li M, Fang Y, Qian K, Tang Y, Wu X, Lei X, Li X, Liu Q, et al. Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma. Biomed Pharmacother. 2019;118:109270.","journal-title":"Biomed Pharmacother"},{"key":"4744_CR28","doi-asserted-by":"publisher","first-page":"110435","DOI":"10.1016\/j.exer.2025.110435","volume":"258","author":"Y Nakazawa","year":"2025","unstructured":"Nakazawa Y, Nishizawa F, Kawata S, Sugiyama Y, Nagai N, Yamamoto N, Funakoshi-Tago M. TRPV1 attenuates epithelial-mesenchymal transition via calpain-protein tyrosine phosphatase pathway in lens epithelial cells. Exp Eye Res. 2025;258:110435.","journal-title":"Exp Eye Res"},{"issue":"1","key":"4744_CR29","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-023-38318-7","volume":"14","author":"SJ Oh","year":"2023","unstructured":"Oh SJ, Lim JY, Son MK, Ahn JH, Song K-H, Lee H-J, Kim S, Cho EH, Chung J-Y, Cho H, et al. TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway. Nat Commun. 2023;14(1):2691.","journal-title":"Nat Commun"},{"key":"4744_CR30","doi-asserted-by":"publisher","first-page":"109189","DOI":"10.1016\/j.neuropharm.2022.109189","volume":"216","author":"V Fattori","year":"2022","unstructured":"Fattori V, Zaninelli TH, Ferraz CR, Brasil-Silva L, Borghi SM, Cunha JM, Chichorro JG, Casagrande R, Verri WA Jr. Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release. Neuropharmacology. 2022;216:109189.","journal-title":"Neuropharmacology"},{"key":"4744_CR31","doi-asserted-by":"crossref","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protocols Bioinfo 2016, 54:1.30.31\u201331.30.33.","DOI":"10.1002\/cpbi.5"},{"issue":"4","key":"4744_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","volume":"16","author":"Q Lian","year":"2018","unstructured":"Lian Q, Wang S, Zhang G, Wang D, Luo G, Tang J, Chen L, Gu J. HCCDB: a database of hepatocellular carcinoma expression atlas. Genom Proteom Bioinform. 2018;16(4):269\u201375.","journal-title":"Genom Proteom Bioinform"},{"issue":"8","key":"4744_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"D1","key":"4744_CR34","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2021","unstructured":"Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2021;50(D1):D1334\u20139.","journal-title":"Nucleic Acids Res"},{"key":"4744_CR35","doi-asserted-by":"crossref","unstructured":"Liu C-J, Hu F-F, Xie G-Y, Miao Y-R, Li X-W, Zeng Y, Guo A-Y. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 2022, 24(1).","DOI":"10.1093\/bib\/bbac558"},{"issue":"W1","key":"4744_CR36","doi-asserted-by":"publisher","first-page":"W84","DOI":"10.1093\/nar\/gkaf402","volume":"53","author":"J Vendetti","year":"2025","unstructured":"Vendetti J, Harris Nomi L, Dorf Michael V, Skrenchuk A, Caufield JH, Gon\u00e7alves Rafael S, Graybeal John B, Hegde H, Redmond T, Mungall Christopher J, et al. BioPortal: an open community resource for sharing, searching, and utilizing biomedical ontologies. Nucleic Acids Res. 2025;53(W1):W84\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"4744_CR37","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43(Database issue):D805\u2013811.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4744_CR38","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"4744_CR39","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"D1","key":"4744_CR40","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, Shi X, Wang B, Li Z, Ren P, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4744_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12032-022-01943-1","volume":"40","author":"S Bhootra","year":"2023","unstructured":"Bhootra S, Jill N, Shanmugam G, Rakshit S, Sarkar K. DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Med Oncol. 2023;40(2):71.","journal-title":"Med Oncol"},{"issue":"4","key":"4744_CR42","first-page":"575","volume":"19","author":"S van Dam","year":"2017","unstructured":"van Dam S, V\u00f5sa U, van der Graaf A, Franke L, de Magalh\u00e3es JP. Gene co-expression analysis for functional classification and gene\u2013disease predictions. Brief Bioinform. 2017;19(4):575\u201392.","journal-title":"Brief Bioinform"},{"key":"4744_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ebiom.2019.03.022","volume":"42","author":"J Long","year":"2019","unstructured":"Long J, Wang A, Bai Y, Lin J, Yang X, Wang D, Yang X, Jiang Y, Zhao H. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019;42:363\u201374.","journal-title":"EBioMedicine"},{"key":"4744_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/bs.acr.2024.06.005","volume":"163","author":"L Li","year":"2024","unstructured":"Li L, Sun M, Wang J, Wan S. Multi-omics based artificial intelligence for cancer research. Adv Cancer Res. 2024;163:303\u201356.","journal-title":"Adv Cancer Res"},{"issue":"4","key":"4744_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jhep.2024.05.017","volume":"81","author":"J Chen","year":"2024","unstructured":"Chen J, Kaya NA, Zhang Y, Kendarsari RI, Sekar K, Lee Chong S, Seshachalam VP, Ling WH, Jin Phua CZ, Lai H, et al. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and \u2018bad apple\u2019 effect on clinical trajectory. J Hepatol. 2024;81(4):667\u201378.","journal-title":"J Hepatol"},{"key":"4744_CR46","first-page":"243","volume":"8","author":"LV Weber","year":"2016","unstructured":"Weber LV, Al-Refae K, W\u00f6lk G, Bonatz G, Altm\u00fcller J, Becker C, Gisselmann G, Hatt H. Expression and functionality of TRPV1 in breast cancer cells. Breast cancer (Dove Med Press). 2016;8:243\u201352.","journal-title":"Breast cancer (Dove Med Press)"},{"issue":"4","key":"4744_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00432-008-0482-3","volume":"135","author":"G Czifra","year":"2009","unstructured":"Czifra G, Varga A, Nyeste K, Marincs\u00e1k R, T\u00f3th BI, Kov\u00e1cs I, Kov\u00e1cs L, B\u00edr\u00f3 T. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol. 2009;135(4):507\u201314.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4744_CR48","first-page":"837","volume":"36","author":"R Clark","year":"2016","unstructured":"Clark R, Lee SH. Anticancer Properties of Capsaicin Against Human Cancer. Anticancer Res. 2016;36(3):837\u201343.","journal-title":"Anticancer Res"},{"issue":"2","key":"4744_CR49","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1002\/mco2.139","volume":"3","author":"R Gao","year":"2022","unstructured":"Gao R, Meng M, Zhou X, Yu M, Li Z, Li J, Wang X, Song Y, Wang H, He J. TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration. MedComm (2020). 2022;3(2):e139.","journal-title":"MedComm (2020)"},{"issue":"1","key":"4744_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, Lin D, Wu C. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Therapy. 2024;9(1):149.","journal-title":"Signal Transduct Target Therapy"},{"key":"4744_CR51","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.biopha.2020.111030","volume":"133","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Huang Y, Dai T, Hua Z, Xu J, Lin Y, Han L, Yue X, Ho L, Lu J, et al. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Biomed Pharmacother. 2021;133:111030.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4744_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11033-024-09756-3","volume":"51","author":"A Kipcak","year":"2024","unstructured":"Kipcak A, Sezan S, Karpat O, Kaya E, Baylan S, Sariyar E, Yandim C, Karagonlar ZF. Suppression of CTC1 inhibits hepatocellular carcinoma cell growth and enhances RHPS4 cytotoxicity. Mol Biol Rep. 2024;51(1):799.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"4744_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.31083\/j.fbl2910357","volume":"29","author":"S Li","year":"2024","unstructured":"Li S, Fan T, Wu C. FBW7-Mediated Degradation of CHD3 suppresses hepatocellular carcinoma metastasis and stemness to enhance oxaliplatin sensitivity. Front Biosci (Landmark Ed). 2024;29(10):357.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"11","key":"4744_CR54","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012\u201327.","journal-title":"Trends Genet"},{"issue":"4","key":"4744_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168\u201374.","journal-title":"Trends Genet"},{"issue":"35","key":"4744_CR56","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1038\/sj.onc.1205608","volume":"21","author":"DJ Smiraglia","year":"2002","unstructured":"Smiraglia DJ, Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene. 2002;21(35):5414\u201326.","journal-title":"Oncogene"},{"issue":"4","key":"4744_CR57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1045","volume":"3","author":"PW Laird","year":"2003","unstructured":"Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3(4):253\u201366.","journal-title":"Nat Rev Cancer"},{"key":"4744_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-61779-612-8_5","volume":"863","author":"M Yang","year":"2012","unstructured":"Yang M, Park JY. DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol. 2012;863:67\u2013109.","journal-title":"Methods Mol Biol"},{"key":"4744_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.gene.2019.06.023","volume":"710","author":"E Bouras","year":"2019","unstructured":"Bouras E, Karakioulaki M, Bougioukas KI, Aivaliotis M, Tzimagiorgis G, Chourdakis M. Gene promoter methylation and cancer: An umbrella review. Gene. 2019;710:333\u201340.","journal-title":"Gene"},{"key":"4744_CR60","doi-asserted-by":"crossref","unstructured":"Herman-Sanchez N, Serrano-Jimenez M, Amado V, Rodriguez-Peralvarez M, Luque RM, Lopez-Canovas JL, Gahete MD. Characterization and targeting of serpins alteration in chronic liver disease and hepatocellular carcinoma. In: Endocrine Abstracts: 2024: Bioscientifica; 2024.","DOI":"10.1530\/endoabs.99.OC7.5"},{"issue":"43","key":"4744_CR61","doi-asserted-by":"publisher","first-page":"e31376","DOI":"10.1097\/MD.0000000000031376","volume":"101","author":"M Hou","year":"2022","unstructured":"Hou M. Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases. Med (Baltim). 2022;101(43):e31376.","journal-title":"Med (Baltim)"},{"issue":"2","key":"4744_CR62","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3892\/mmr.2015.4646","volume":"13","author":"X Lu","year":"2016","unstructured":"Lu X, Sun W, Tang Y, Zhu L, Li Y, Ou C, Yang C, Su J, Luo C, Hu Y, et al. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison. Mol Med Rep. 2016;13(2):1172\u20138.","journal-title":"Mol Med Rep"},{"issue":"6","key":"4744_CR63","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4251\/wjgo.v16.i6.2571","volume":"16","author":"QS Ren","year":"2024","unstructured":"Ren QS, Sun Q, Cheng SQ, Du LM, Guo PX. Hepatocellular carcinoma: An analysis of the expression status of stress granules and their prognostic value. World J Gastrointest Oncol. 2024;16(6):2571\u201391.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"4744_CR64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4254\/wjh.v16.i3.353","volume":"16","author":"T Gupta","year":"2024","unstructured":"Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol. 2024;16(3):353\u201365.","journal-title":"World J Hepatol"},{"key":"4744_CR65","doi-asserted-by":"crossref","unstructured":"Refolo MG, Messa C, Guerra V, Carr BI, D\u2019Alessandro R. Inflammatory Mechanisms of HCC Development. Cancers (Basel) 2020, 12(3).","DOI":"10.3390\/cancers12030641"},{"key":"4744_CR66","doi-asserted-by":"crossref","unstructured":"Tan ES, Knepper TC, Wang X, Permuth JB, Wang L, Fleming JB, Xie H. Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer. Cancers (Basel) 2022, 14(9).","DOI":"10.3390\/cancers14092223"},{"key":"4744_CR67","doi-asserted-by":"crossref","unstructured":"Carey-Smith SL, Kotecha RS, Cheung LC, Malinge S. Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer. Int J Mol Sci 2024, 25(13).","DOI":"10.3390\/ijms25136815"},{"issue":"6","key":"4744_CR68","doi-asserted-by":"publisher","first-page":"321","DOI":"10.21037\/atm.2020.02.98","volume":"8","author":"M Shi","year":"2020","unstructured":"Shi M, Wang Y, Tang W, Cui X, Wu H, Tang Y, Wang P, Wu W, Zhang H. Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma. Ann Transl Med. 2020;8(6):321.","journal-title":"Ann Transl Med"},{"key":"4744_CR69","doi-asserted-by":"publisher","first-page":"1057302","DOI":"10.3389\/fgene.2022.1057302","volume":"13","author":"Y Tao","year":"2022","unstructured":"Tao Y, Li X, Zhang Y, He L, Lu Q, Wang Y, Pan L, Wang Z, Feng C, Xie Y, et al. TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study. Front Genet. 2022;13:1057302.","journal-title":"Front Genet"},{"issue":"19","key":"4744_CR70","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002;99(19):12293\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4744_CR71","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793\u2013800.","journal-title":"Nat Med"},{"issue":"1","key":"4744_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-021-01310-0","volume":"20","author":"X Huang","year":"2021","unstructured":"Huang X, Zhang G, Tang T, Liang T. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. Mol Cancer. 2021;20(1):44.","journal-title":"Mol Cancer"},{"issue":"1","key":"4744_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12967-023-04386-y","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Advances in radiotherapy and immunity in hepatocellular carcinoma. J Translational Med. 2023;21(1):526.","journal-title":"J Translational Med"},{"issue":"6","key":"4744_CR74","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3322\/caac.70018","volume":"75","author":"D Moris","year":"2025","unstructured":"Moris D, Martinino A, Schiltz S, Allen PJ, Barbas A, Sudan D, King L, Berg C, Kim C, Bashir M, et al. Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. Cancer J Clin. 2025;75(6):498\u2013527.","journal-title":"Cancer J Clin"},{"issue":"7","key":"4744_CR75","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.18632\/aging.204645","volume":"15","author":"B Fu","year":"2023","unstructured":"Fu B, Zhou M, Song G, Zeng H, Gong Y, Jiang Y, Ke Y, Huang D, Peng H, Li Q. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma. Aging. 2023;15(7):2734\u201371.","journal-title":"Aging"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04744-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:04:53Z","timestamp":1778047493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4744"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04744-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"698"}}